MAP3K8 and ovarian cancer: Moreover, the combined inhibition of both MAP3K8 and p90RSK did not show any additive effect, suggesting that p90RSK is the only key player downstream of MAP3K8, involved in regulating cyclin D1 in ovarian cancer cells.